Subscribe To
Zymeworks announces participation in upcoming investor conference
VANCOUVER, British Columbia--( BUSINESS WIRE )--Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctiona...
December 21, 2022, 7:30 am
Enveric biosciences to present at the 6th annual neuroscience innovation forum and biotech showcase during "j.p. morgan health care week 2023"
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the...
December 21, 2022, 7:30 am
Axonics to present at the 41st annual j.p. morgan healthcare conference
IRVINE, Calif.--( BUSINESS WIRE )--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing ...
December 21, 2022, 6:00 am
Poolbeg pharma identifies possible new rsv treatments as infection rates soar
Poolbeg Pharma said it had identified five potential new drug candidates from its Respiratory Syncytial Virus (RSV) AI collaboration with One Three B...
December 21, 2022, 2:32 am
Graphene manufacturing group reports improved heat transfer on aluminium with its novel thermal-xr coating
Graphene Manufacturing Group Ltd (TSX-V:GMG, OTC:GMGMF) (GMG) has shared the impressive results of heat transfer demonstrations for aluminium coated w...
December 20, 2022, 9:43 am
Zhittya genesis medicine announces: free zoom webinar: zhittya parkinson’s disease research study: 6-month patient follow-up report
First-In-Human Study of FGF-1 into the Brain with a novel Intranasal Treatment for Parkinson’s Diseas...
December 19, 2022, 5:00 pm
Madrigal pharmaceuticals shares soar on positive trial results for its nash and liver fibrosis drug resmetirom
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) shares have soared more than 250% after the biopharmaceutical company shared positive topline results from ...
December 19, 2022, 10:41 am
Why is madrigal pharmaceuticals (mdgl) stock up 216% today?
Madrigal Pharmaceuticals (NASDAQ: MDGL ) stock is rocketing higher on Monday after sharing results from its no...
December 19, 2022, 9:48 am
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th
CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursui...
December 18, 2022, 9:00 pm
Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th
CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...
December 18, 2022, 4:00 pm
Athenex exits 503b sterile compounding business
Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year BUFFALO, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) — Athenex, Inc. (NASD...
December 16, 2022, 1:00 pm
Genprex boosts its diabetes gene therapy program with the license of additional technology from the university of pittsburgh
Genprex, Inc. (NASDAQ:GNPX) revealed that it has struck an agreement with the University of Pittsburgh for a worldwide, exclusive license to some pat...
December 15, 2022, 9:16 am
Xeris biopharma to proceed with phase ii study of levothyroxine for hypothyroidism
Xeris Biopharma Holdings (NASDAQ:XERS) Inc announced that it will proceed with a Phase II study in patients for its ...
December 15, 2022, 9:03 am
Sab biotherapeutics cmo selected to present at the january 2023 biotech showcase in san francisco
SIOUX FALLS, S.D., Dec. 15, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a ...
December 15, 2022, 8:30 am
Founder of astrolucha, and creator of the netflix original series selena, launches web3 artists collective
Astrolucha is designed to fund independent creators through a novel blockchain structure that will also...
December 14, 2022, 1:00 am
Nurix therapeutics presents positive clinical results from its novel btk degrader (nx-2127) at the 64th american society of hematology (ash) annual meeting
Treatment with NX-2127 provides clinically meaningful responses in heavily pretreated chronic lymphocytic leukemia (CLL) patients regardless of Bruton...
December 12, 2022, 10:30 pm
Consolidated water brings water where it is scarce, appears undervalued
Consolidated Water Co. Ltd. supplies potable water, water for reuse, and offers water-related products. I am optimistic about the company's SWRO syste...
December 12, 2022, 6:33 pm
Metafora partner wugen to present data supporting clinical development of wu-nk-101 for relapsed / refractory aml at the american society of hematology's (ash) 64th annual meeting
PARIS, France & NEW ORLEANS, La.--( BUSINESS WIRE )--METAFORA biosystems announces that its partner Wugen presented data supporting clinical developme...
December 12, 2022, 3:23 pm
Opthea announce mst access hosted conference call with professor jason s. slakter, md
MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing ...
December 12, 2022, 10:08 am
Top 5 insights advisors gave vettafi in 2022
On a weekly basis, VettaFi has sought to respond to advisor needs in a novel way. We asked questions ab...
December 12, 2022, 9:33 am